FARO, DENISE CRISTIANA
 Distribuzione geografica
Continente #
NA - Nord America 308
EU - Europa 266
AS - Asia 199
SA - Sud America 48
AF - Africa 12
Totale 833
Nazione #
US - Stati Uniti d'America 303
IT - Italia 208
SG - Singapore 102
CN - Cina 60
BR - Brasile 45
KR - Corea 20
RU - Federazione Russa 16
NL - Olanda 9
CI - Costa d'Avorio 8
FI - Finlandia 7
GB - Regno Unito 6
DE - Germania 5
AT - Austria 4
BD - Bangladesh 4
CA - Canada 3
HK - Hong Kong 3
IE - Irlanda 3
PH - Filippine 3
BE - Belgio 2
BY - Bielorussia 2
JP - Giappone 2
MX - Messico 2
TR - Turchia 2
AO - Angola 1
AR - Argentina 1
CH - Svizzera 1
FR - Francia 1
IN - India 1
IR - Iran 1
KE - Kenya 1
MK - Macedonia 1
SA - Arabia Saudita 1
SN - Senegal 1
UA - Ucraina 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 833
Città #
Santa Clara 149
Singapore 91
Catania 50
Chicago 50
Hefei 38
Civitanova Marche 36
Boardman 22
Seoul 20
Palermo 15
Rome 15
Milan 12
Abidjan 8
Ashburn 8
Bologna 6
Lappeenranta 6
São Paulo 6
Cagliari 5
Moscow 5
Naples 5
Beijing 4
Los Angeles 4
Messina 4
Pozzallo 4
Salzburg 4
Agerola 3
Brooklyn 3
Dublin 3
Hong Kong 3
Munich 3
Araraquara 2
Bari 2
Bernareggio 2
Brussels 2
Bussero 2
Charlotte 2
Glasgow 2
Hamburg 2
Mexico City 2
Minsk 2
Misterbianco 2
Narni 2
Newham 2
Omsk 2
Padua 2
Palazzolo sull'Oglio 2
Phoenix 2
Quezon City 2
Springfield 2
St Petersburg 2
Syracuse 2
Tessennano 2
Tokyo 2
Alvorada do Sul 1
Atlanta 1
Avola 1
Bocaiúva 1
Bonito 1
Brasília 1
Bursa 1
Camden 1
Campinas 1
Canela 1
Caraguatatuba 1
Carney 1
Caucaia 1
Chatham 1
Chengdu 1
Chongqing 1
Collecchio 1
Columbus 1
Curitiba 1
Dakar 1
Dammam 1
Dandridge 1
Dhaka 1
Divinésia 1
Feira de Santana 1
Frutal 1
Gatchina 1
Goiânia 1
Guarulhos 1
Handan 1
Hayward 1
Itabuna 1
Itaituba 1
Ivanovo 1
Jinzhong 1
Johannesburg 1
Juazeiro 1
Las Vegas 1
League City 1
Linyi 1
London 1
Longyan 1
Luanda 1
Luoyang 1
Maida 1
Makariv 1
Maria da Fé 1
Monte Azul Paulista 1
Totale 676
Nome #
Pharmacological and Clinical Appraisal of Factor XI Inhibitor Drugs. 62
The added value of the HFA/ICOS score in the prediction of chemotherapy-related cardiac dysfunction in breast cancer 62
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke : JACC State-of-the-Art Review 62
Assessment of Noninferiority Margins in Cardiovascular Medicine Trials 53
Speckle Tracking Echocardiography- derived parameters as new prognostic markers in Hypertrophic Cardiomyopathies 49
Percutaneous interventions for pulmonary embolism 41
Sex Differences in Anderson–Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women 40
Systemic Vascular Resistance and Myocardial Work Analysis in Hypertrophic Cardiomyopathy and Transthyretin Cardiac Amyloidosis with Preserved Left Ventricular Ejection Fraction. 38
Comparison of personality and psychopathology in patients with Fabry disease and patients with end-stage renal disease: a preliminary study 38
SPECKLE-TRACKING ECHOCARDIOGRAPHY FOR ARRHYTHMIC RISK ASSESSMENT IN HYPERTROPHIC AND FABRY CARDIOMYOPATHY 36
Interdisciplinary Multidimensional Assessment of Transthyretin Amyloidosis before and after Tafamidis 35
Strain and Myocardial Work Index during Echo Exercise to Evaluate Myocardial Function in Athletes 34
Eligibility to Intensified Antithrombotic Regimens for Secondary Prevention in Patients Who Underwent Percutaneous Coronary Intervention 33
Left Atrial Strain Imaging by Speckle Tracking Echocardiography: The Supportive Diagnostic Value in Cardiac Amyloidosis and Hypertrophic Cardiomyopathy 33
Inflammation, Oxidative Stress, and Endothelial Dysfunction in the Pathogenesis of Vascular Damage: Unraveling Novel Cardiovascular Risk Factors in Fabry Disease 33
Pharmacology and Clinical Development of Factor XI Inhibitors 33
New applications of speckle tracking echocardiography in the evaluation of the athlete's heart 32
Myocardial Work Appraisal in Transthyretin Cardiac Amyloidosis and Nonobstructive Hypertrophic Cardiomyopathy 32
Association of trial characteristics with simultaneous publication and its impact on citations and mentions: a cross-sectional study 31
Complete Percutaneous Coronary Revascularization in Acute Coronary Syndromes With Multivessel Coronary Disease: A Systematic Review 31
Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects 24
PERIPROCEDURAL HEARTATTACK: PRE- AND PERI-PROCEDURAL RISK FACTORS AND SHORT-TERM PROGNOSTIC IMPLICATIONS 14
Relationship between Capillaroscopic Architectural Patterns and Different Variant Subgroups in Fabry Disease: Analysis of Cases from a Multidisciplinary Center 13
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis 7
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: a report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of Cardiology 7
Totale 873
Categoria #
all - tutte 4.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.050


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202316 0 0 0 0 0 3 0 2 10 0 1 0
2023/2024102 0 5 4 3 0 6 5 20 7 7 18 27
2024/2025695 42 90 49 52 102 78 29 15 23 58 62 95
2025/202660 60 0 0 0 0 0 0 0 0 0 0 0
Totale 873